The S&P 500 Dividend Aristocrats ($NOBL) uses the S&P 500 as its basis and targets the index’s components that have increased their dividends annually for at least the past 25 years. The benchmark includes a minimum of 40 names and be equal weighted with no individual sector comprising more than 30% of the fund’s assets.
This index should form a major part of your long term portfolio for its multi-decade dividend payout track record.
Shorter term, it is likely to trade up to $59 & slightly above before hitting long term channel resistance.
Jardine Matheson Holdings Limited ($SGX:J36) has gained > 200% since its 2009, compared to the S&P500 which gained >300% over the same period. So, is it time for $SGX:J36 to catch up? The Singapore Straits Times Index (STI) itself has underperformed the S&P500 since 2009, so the outperformance of $SGX:J36 soon is key to the STI catching up to S&P500.
$SGX:J36 has been in a trading range of $48.70 to $69.50, its 161.8% to 261.8% fib extension. If it clears $69.50 with strength, its next upside target is $86, followed by $100.
The Market Vectors Gold Miners ETF ($GDX) is about to get jiggy. Big triangle about to break out… Inflation? Deflation? Covfefe? Watch this space…
Amongst the FANG of four, $GOOGL is perhaps the most widely used since it dominates the mobile usage market via Android devices. Search engines, browsers, apps store, you name & it probably has it.
So what else do we not know about them? There are hidden gems within it that has not reached commercialisation yet but will represent its future revenue story. Eg. Boston Dynamics, a robotics firm, its new Youtube original shows, Andy Rubin’s new “Essential Home” smart home device etc etc.
It has low gearing, decent ROE & above sector average net margins. Fundamentally its sound but its multiples aren’t cheap, but technically its bull case isn’t over as it broke into record highs recently. Some consolidation is expected soon as it broke above its 161.8% fib extension recently, so unless its support fails, more accumulation would not be surprising on strong pullbacks.
Equinix ($EQIX) connects the world’s leading businesses to their customers, employees and partners in 44 markets across five continents. $EQIX is a data center company. Riding on the ecommerce, cloud services and data usage boom, its share price has been on a big upcycle.
From its chart, it likely that it still has more room to run up to its final 261.8% fib extension from its 2009 lows of about $550. A pullback soon should be seen as a buying opportunity. Of the listed data center REITs in the NASDAQ, $EQIX is the most globally diversified.
Compagnie Generale des Etablissements Michelin SCA (Michelin SCA) is a France-based company, which is mainly engaged in the manufacture and distribution of tires for a variety of vehicles.
It recently broke above its €103.00 long term resistance, and is now likely heading to its 161.8% fib extension from 2009 lows. If it stays above €113.20, its bull trend is likely to persist.
Can the ecommerce king continue its stratospheric rise? It has a clear support line from 2016, and at the moment the thing to be worried about is its overbought weekly RSI, which in its recent history, its price has been sideways for the overbought period. It has just cleared its 161.8% fib extension from 2015 lows, so some consolidation can be expected soon. Unless it breaks that support line, this “FANG” still has bite left.
Blackmores Limited is engaged in the development, sales and marketing of health products for humans and animals, including vitamins, herbal and mineral nutritional supplements.. It has declined >50% in the past 2 years, but it may finally be turning the corner as its RSI is showing relative strength & its trading between its 50% – 61.8% fib retracement from its 2015 highs. The safer long trade would be to wait for it to break above $120 with strength. Going long now would be higher risk due to it being stuck in its trading range of $98 – $120.
Regeneron Pharmaceuticals Inc, $REGN, is a biopharmaceutical firm that discovers, invents, develops, makes and commercializes medicines for the treatment of serious medical conditions.
$REGN is trying to break above its year long rising resistance. A strong break above this will be very bullish, & will set it up to go back to its 38.2% fib retracement from its 2015 highs.
Paychex has been on a tear since 2009, so how much legs does it have left? It needs to hold its rising support with strength, & safer long trade would be to wait for it break above $61.87, its clear major resistance. Beyond that, its first target is around $67.90, before moving towards its 161.8% fib extension from 2009 of $87.00.